yego.me
💡 Stop wasting time. Read Youtube instead of watch. Download Chrome Extension

The Challenges with Cancer Trials | Breakthrough


2m read
·Nov 11, 2024

ANDRE CHOULIKA: We didn't have any intention of injecting these type of vials to patient because we needed a lot of vials to be able to file our clinical trial application. And this was planned to be done with the University College London.

NARRATOR: Before any new medication or therapy is considered safe and effective, it must first be rigorously tested through clinical trials. These trials are fundamental in determining an experimental treatment's dosage and safety and to identify any possible side effects. At the University College London, Great Ormond Street Institute of Child Health, Professor Waseem Qasim was working with Cellectis as the principal investigator, taking the universal CAR T-cells from the lab to trials.

Normally, this process can take over a decade, with nearly endless layers of approval. So our questions were what do you do if your patient is already so unwell that you can't collect cells; or has had so much chemotherapy that there's no white blood cells left to collect, that you think are going to be useful; how do you do this process in a way that can be done quickly and delivered back to the patient in a timely manner?

And the answer to that is perhaps being able to use a product, a cell product, that's been made beforehand, that can be given back to multiple patients. Now in order to do that, we have to overcome the barrier of transplantation, which means if I put my cells into a nonmatched individual, the cells firstly will want to react against that individual because they will know the individuals is foreign. And secondly, the person receiving the cells will try and reject them because they know the cells are not their own.

NARRATOR: In affiliation with Professor Qasim, Doctor Paul Veys works on the front line with patients who desperately need new cancer treatment options. I'll have treated well over 3,000 patients and at least 600 of those will have gone wrong. So there's a lot of patients that we lose. It's unsuccessful. You've got to be able to come in the next day. Even from our failures, we've learned lots. And if we hadn't gone through those failures, we wouldn't be having some of the successes we have today.

Has the chest always been good? He's not had any big chest infections? NURSE: No. It's not good. Let's warm it up. Sit forward again. Yeah. Perfect. OK. Big breaths.

More Articles

View All
The Crux Episode 4 | Full Episode | National Geographic
Growing up, I watched the Olympics when they were in Vancouver, and I thought, wow, it would be really cool to be one of those athletes one day. But I never thought it would actually come true. It did on the first Olympics ever, which is like even more sp…
Interpreting graphs with slices | Multivariable calculus | Khan Academy
So in the last video, I described how to interpret three-dimensional graphs. I have another three-dimensional graph here; it’s a very bumpy guy. This happens to be the graph of the function ( f(x,y) = \cos(x) \cdot \sin(y) ). You know, I could also say th…
AI for Digital SAT prep
All right, everybody! Well, we are going to take time to now introduce, uh, myself as the host and then I’ll let my amazing panelists go ahead and introduce themselves. So nice to meet you! My name is Danielle Sullivan. I am Senior Manager of District Par…
Charlie Munger: How to Invest in 2024
That’s a very simple set of ideas. The reason that our ideas have not spread faster is they’re too simple. If you’re not confused by what’s going on, you’re not paying attention. This Charlie Munger quote perfectly sums up what’s happening in the stock ma…
How Will You Diversify a $100,000,000 Portfolio? (Asset Allocation)
If you had $1100 million, how would you invest it? How much of it would go where? Well, as of 2024, according to the Wealth Report by Douglas, Elon, and KN Frank’s Flagship Report, there are around 626,000 ultra-high net worth individuals in the world. Th…
Diane Greene at Startup School 2013
Hi there. I’ve been in this auditorium once before. I think it was before you were born; it was 1989. I was working for Tandem Computers, which was one of the biggest companies in Silicon Valley. The very wonderful, irreverent founder CEO was holding an a…